[Comment on the letter to the editor "Anesthesia with remifentanil for thoracoscopic thymectomy in a girl with myasthenia gravis"].
González
A M
AM
D000367:Age Factors; D000771:Anesthesia, Intravenous / Q000379:methods*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D001919:Bradycardia / Q000139:chemically induced / Q000517:prevention & control; D002648:Child; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D000075202:Contraindications; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous / Q000009:adverse effects; D007431:Intraoperative Complications / Q000139:chemically induced / Q000517:prevention & control; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D009157:Myasthenia Gravis / Q000209:etiology / Q000601:surgery*; D010477:Perfusion; D010880:Piperidines / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D000077208:Remifentanil; D013906:Thoracoscopy / Q000379:methods*; D013934:Thymectomy / Q000379:methods*
D018686:Anesthetics, Intravenous; D010880:Piperidines; D000077208:Remifentanil